Interventional medical devices, device systems, and fixation components thereof

Information

  • Patent Grant
  • 12251559
  • Patent Number
    12,251,559
  • Date Filed
    Monday, May 3, 2021
    4 years ago
  • Date Issued
    Tuesday, March 18, 2025
    4 months ago
Abstract
A fixation mechanism of an implantable medical device is formed by a plurality of tines fixedly mounted around a perimeter of a distal end of the device. Each tine may be said to include a first segment fixedly attached to the device, a second segment extending from the first segment, and a third segment, to which the second segment extends. When the device is loaded in a lumen of a delivery tool and a rounded free distal end of each tine engages a sidewall that defines the lumen, to hold the tines in a spring-loaded condition, the first segment of each tine, which has a spring-biased pre-formed curvature, becomes relatively straightened, and the third segment of each tine, which is terminated by the free distal end, extends away from the axis of the device at an acute angle in a range from about 45 degrees to about 75 degrees.
Description
FIELD OF THE DISCLOSURE

The present disclosure pertains to medical device systems, and, more particularly, to relatively compact implantable medical devices thereof and associated fixation components.


BACKGROUND

The traditional implantable cardiac pacemaker includes a pulse generator device to which one or more flexible elongate lead wires are coupled. The device is typically implanted in a subcutaneous pocket, remote from the heart, and each of the one or more lead wires extends therefrom to a corresponding electrode, coupled thereto and positioned at a pacing site, either endocardial or epicardial. Mechanical complications and/or MM compatibility issues, which are sometimes associated with elongate lead wires and well known to those skilled in the art, have motivated the development of implantable cardiac pacing devices that are wholly contained within a relatively compact package, the entirety of which is configured for implant in close proximity to the pacing site. FIG. 1 is a schematic that shows a potential cardiac implant site for such a device within an appendage 102 of a right atrium RA. An implanting physician may employ a delivery tool 400 to deploy a relatively compact medical device to the site, for example, after maneuvering tool 400, with the device loaded therein, up through the inferior vena cava IVC and into the right atrium RA.


BRIEF SUMMARY

Embodiments of medical device systems disclosed herein include an implantable medical device and a delivery tool, wherein the device has a fixation mechanism formed by a plurality of tines fixedly mounted and spaced from one another around a perimeter of a distal end of the device, and the tool includes a tubular sidewall that defines a lumen into which the device may be loaded, the lumen having a distal opening through which the device may be deployed. In some embodiments, each tine of the device fixation mechanism includes: a first segment fixedly attached to the device and extending therefrom; a second segment extending from the first segment; and a third segment, to which the second segment extends, the third segment having a rounded free distal end spaced from the perimeter of the device housing distal end; and wherein: the first segment has a spring-biased pre-formed curvature, extending distally from the device distal end, and then sweeping laterally outward from the axis of the device and then proximally to the second segment; the second segment is pre-formed to extend proximally along a relatively straight line to the third segment, the relatively straight line of the second segment being oriented, by the spring-biased preformed curvature of the first segment, to intersect the axis of the device at an acute angle of between about 30 degrees and about 50 degrees; the third segment has a deformable pre-formed curvature that extends back toward the axis of the device such that, when the curvature of the third segment is un-deformed, the second and third segments enclose an angle in a range from about 70 degrees to about 120 degrees; and the tines are each configured such that when the device is loaded in the lumen of the tool and the rounded free distal end of the third segment of each tine engages the delivery tool sidewall to hold the tines in a spring-loaded condition, the first segment of each tine becomes relatively straightened, and the third segment of each tine extends away from the axis of the device at an acute angle in a range from about 45 degrees to about 75 degrees.


According to some embodiments, the aforementioned tines are part of a tissue penetrating fixation component that also includes a base configured to be fixedly attached to the device so that a perimeter of the component extends around an electrode of the device, and so that a longitudinal axis of the component is generally aligned along that of the device. The plurality of tines extend from the base, and each tine includes: a proximal, spring portion (corresponding to the aforementioned first segment) being fixedly attached to the base and having a spring-biased pre-formed curvature, the pre-formed curvature, in proximity to the base, extending in a first direction, generally parallel to the axis of the component, and then sweeping laterally, outward from the axis; and a distal portion (corresponding to the aforementioned second and third segments) including a proximal section, a hook section, and tip section terminated by a rounded free distal end, the proximal section extending from the proximal, spring portion and being pre-formed to extend in a second direction and along a relatively straight line to the hook section, the proximal section being oriented, by the spring-biased pre-formed curvature of the proximal, spring portion, so that the second direction is generally opposite the first direction, and the relatively straight line intersects the axis at an acute angle of between about 30 degrees and about 50 degrees, the hook section having a deformable pre-formed curvature that extends from the proximal section back toward the axis of the component, the tip section being pre-formed to extend along a relatively straight line from the hook section to the rounded free distal end, and the tip section being oriented by the pre-formed curvature of the hook section, when un-deformed, to extend toward the axis of the component, such that the tip section and the proximal section enclose an angle in a range from about 70 degrees to about 120 degrees; and wherein: when the device, having the fixation component fixedly attached thereto, is loaded within a tubular sidewall of a delivery tool, so that the rounded free distal end of each tine of the component engages an inner surface of the sidewall in proximity to a distal opening of the tool, to hold the proximal, spring portion of each tine of the component in a spring-loaded condition, each tip section of the distal portion extends away from the axis of the component at an acute angle in a range from about 45 degrees to about 75 degrees for deployment of the corresponding rounded free distal end out from the distal opening of the tool tubular sidewall; and upon deployment of the rounded free distal end of each tine, the tip section of each distal portion rotates away from the axis to approach an angle of 90 degrees, relative to the axis, in response to an initial release of the spring-loaded condition of the corresponding proximal, spring portion.





BRIEF DESCRIPTION OF THE DRAWINGS

The following drawings are illustrative of particular embodiments of the present invention and therefore do not limit the scope of the invention. The drawings are not to scale (unless so stated) and are intended for use in conjunction with the explanations in the following detailed description. Embodiments will hereinafter be described in conjunction with the appended drawings wherein like numerals denote like elements, and:



FIG. 1 is a schematic diagram showing an exemplary cardiac implant site for which embodiments of the present invention are particularly suited;



FIG. 2A is a plan view of a relatively compact implantable medical device, according to some embodiments;



FIG. 2B is a schematic section showing the device of FIG. 2A implanted, according to some embodiments and methods;



FIG. 3A is an elevation view of an exemplary fixation component which may be employed by the device of FIG. 2A, according to some embodiments;



FIG. 3B is an end view of the component of FIG. 3A, according to some embodiments;



FIG. 3C is a plan view of a portion of the component of FIGS. 3A-B, prior to forming, according to some embodiments;



FIG. 3D is a plan view of a portion of the component of FIGS. 3A-B, prior to forming, according to some alternate embodiments;



FIG. 4 is a plan view of a medical device system with a partial cut-away section, according to some embodiments;



FIG. 5A is a schematic showing a spring loaded condition of the fixation component of the atrial portion of the device, according to some embodiments;



FIG. 5B is a schematic showing an initial release of the fixation component from the spring loading shown in FIG. 5A;



FIG. 5C is a schematic showing rotation for initial penetration of the fixation component after the initial release of FIG. 5B;



FIG. 5D is a schematic showing fixation component movement, subsequent to initial penetration;



FIG. 5E is a schematic showing fixation component movement, subsequent to penetration;



FIG. 5F is a schematic showing fixation component movement, subsequent to penetration;



FIG. 6A is an elevation view of an exemplary fixation component which may be employed by the device of FIG. 2A, according to some additional embodiments;



FIG. 6B is an end view of the component of FIG. 6A, according to some additional embodiments;



FIG. 6C is a plan view of a portion of the component of FIGS. 6A-B, prior to forming, according to some embodiments; and



FIG. 6D is a plan view of a portion of the component of FIGS. 6A-B, prior to forming, according to some alternate embodiments.





DETAILED DESCRIPTION

The following detailed description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the following description provides practical examples, and those skilled in the art will recognize that some of the examples may have suitable alternatives.



FIG. 2A is a plan view of a relatively compact implantable medical device 20, according to some embodiments. FIG. 2A illustrates device 20 including a hermetically sealed housing 205, preferably formed from a biocompatible and biostable metal such as titanium, which contains a pulse generator (e.g., a power source and an electronic controller—not shown), a fixation mechanism 30, and an electrode 206, which is spaced apart from a distal end 202 of housing 205, for example, being coupled to the pulse generator by a conductor of an hermetic feedthrough assembly (not shown) that is constructed according to methods known to those skilled in the art of implantable medical devices. FIG. 2A further illustrates device 20 including a holding member 209 mounted to a proximal end 201 of housing 205, wherein holding member 209 is configured for temporarily tethering device 20 to a delivery tool, such as tool 400, according to methods known in the art.


Housing 205 may be overlaid with an insulative layer, for example, medical grade polyurethane, parylene, or silicone, and, with further reference to FIG. 2A, another electrode 207 of device 20 may be formed by removing a portion of the insulative layer to expose the metallic surface of housing 205. According to the illustrated embodiment, electrode 206 may function in conjunction with electrode 207 for bipolar pacing and sensing, when elastically deformable tines 303 of fixation mechanism 30 hold electrode 206 in intimate tissue contact at a target implant site, for example, within right atrial appendage 102 as illustrated schematically in FIG. 2B.


In FIG. 2A, one of tines 303 is shown divided into first, second, and third segments S1, S2, S3, each of which is pre-formed into, and elastically deformable from, the illustrated shape thereof. According to the illustrated embodiment, first segment S1 is fixedly attached to distal end 202 of device housing 205 and extends around a pre-formed curvature to second segment S2, which extends proximally along a relatively straight line to third segment S3. FIG. 2A illustrates third segment S3 extending around a pre-formed curvature to a free distal end 352 of tine 303.



FIG. 2B is a schematic section showing device 20 implanted in right atrium RA (FIG. 1), according to some embodiments and methods. With reference to FIG. 2B, a portion the right atrial wall, for example, in appendage 102, is shown having a laminate structure that includes an inner layer of pectinate muscle PM and an outer layer of visceral pericardium VP, which forms the epicardial surface. FIG. 2B illustrates device 20 secured at the implant site by tines 303 of fixation mechanism 30 penetrating through the layer of pectinate muscle PM without perforating through visceral pericardium VP, which could result in pericardial effusion. Tines 303 of mechanism 30, according to embodiments disclosed herein, are configured for spring-loaded release, upon deployment out through a distal opening 403 of a lumen 435 of delivery tool 400, as described below in conjunction with FIGS. 4 and 5B-C, so that tine free distal end 352 penetrates pectinate muscle PM without perforating visceral pericardium VP. It should be noted that alternate suitable implant sites for embodiments of fixation member tines described herein can be along any endocardial surface defined by pectinate muscle PM.



FIGS. 3A-B are elevation and end views of a fixation component 300 that forms fixation mechanism 30, according to some embodiments. FIGS. 3A-B illustrate component 300 including a base 301 from which a plurality of tines 303 extend, being spaced apart from one another around a perimeter of base 301. Tines 303 are shown in a relaxed, or pre-formed spring-biased condition. In FIG. 3A, a longitudinal axis 3 of component 300 is shown being defined by base 301 such that, when base 301 is mounted around distal end 202 of device housing 205, and a perimeter of component 300 extends around electrode 206, axis 3 is generally aligned along longitudinal axis 2 of device 20 (FIG. 2A). With reference to FIG. 3B, base 301 may have an inner diameter id of about 0.20 inch and an outer diameter od of about 0.21 inch. Fixation component 300 may be mounted to distal end 202 of device housing 205, for example, in a manner similar to that described for a fixation component 102 in co-pending and commonly assigned United States Patent Application 2012/0172690 (filed on Oct. 28, 2011), which description is hereby incorporated by reference. However, according to some alternate embodiments, fixation mechanism 30 may be separately formed tines 303 (not integrated together with base 301) that are individually mounted to distal end 202 of device housing 205.


Tines 303 are preferably formed from a super-elastic material, for example, a Nickel-Titanium alloy (Nitinol). Fixation component 300 may be cut from a medical grade Nitinol tubing that conforms to the chemical, physical, mechanical, and metallurgical requirements of the ASTM F2063 standard, and has a wall thickness of about 0.005 inch. In this case, tines 303 are integrally formed with base 301 and each tine 303 may have a constant thickness t of 0.005 inch±0.001 inch. After cutting the tubing, tines 303 are shaped into the configuration shown in FIG. 3A by bending and holding tines 303, while heat treating according to methods known to those skilled in the art.



FIG. 3A illustrates each tine 303 including a proximal, spring portion 33, which corresponds to first segment S1 of FIG. 2A, and a distal portion 35, which corresponds to second and third segments S2, S3 of FIG. 2A, and which is terminated by free distal end 352. Free distal end 352 is preferably rounded, as shown in FIG. 3A. FIG. 3A further illustrates distal portion 35 including a proximal section 35-P, a hook section 35-H, and a tip section 35-T. The shaped configuration and width of each tine 303, along with the super-elastic stiffness properties of Nitinol, provide a sufficient spring force and structural stiffness for tines 303 to engage tissue for the fixation of device 20 at an implant site when deployed by delivery tool 400, as described in greater detail below. With reference to FIG. 3A, each tine 303 has a width w which is preferably no less than about 0.02 inch, for example, being in a range from about 0.025 inch to about 0.032 inch. Such a width provides the aforementioned structural stiffness, as well as a radiopaque density that facilitates fluoroscopic visualization during and after the implant procedure.


With further reference to FIG. 3A, according to the illustrated embodiment, each proximal, spring portion 33 is fixedly attached to base 301 and has a spring-biased pre-formed curvature, which, in proximity to the base, extends in a first direction d1, generally parallel to axis 3, and then sweeps laterally, outward from axis 3 to distal portion proximal section 35-P. Distal portion proximal section 35-P, according to the illustrate embodiment, is pre-formed to extend in a second direction d2 and along a relatively straight line (dashed line), being oriented, by the spring-biased pre-formed curvature of proximal, spring portion 33, so that second direction d2 is generally opposite first direction d1, and the relatively straight line intersects axis 3 at an acute angle θ. According to some embodiments, angle θ is between about 30 degrees and about 50 degrees. In an exemplary embodiment of component 300, to be employed by an exemplary embodiment of device 20 that has housing 205 sized to an outer diameter of about 0.26 inch (20 French), the spring-biased pre-formed curvature of each proximal, spring portion 33 is defined by a single radius of 0.067 inch±0.010 inch; a distance A between base 301 and each intersection of proximal, spring portion 33 and distal portion proximal segment 35-P is 0.092 inch±0.005 inch; a length of each distal portion proximal segment 35-P is 0.100 inch±0.005 inch; and angle θ is about 45 degrees.


With further reference to FIG. 3A, each distal portion hook section 35-H has a deformable pre-formed curvature that extends from proximal, spring portion 33 back toward axis 3. FIG. 3A further illustrates tip section 35-T of distal portion 35 extending from hook section 35-T along a relatively straight line to rounded free distal end 352. Tip section 35-T is shown oriented by the pre-formed curvature of hook section 35-H, when un-deformed, to extend toward axis 3, such that tip section 35-T and proximal section 35-P are shown enclosing an angle φ, which, according to the illustrated embodiment, is no less than about 90 degrees, but can be up to about 120 degrees. In the aforementioned exemplary embodiment of component 300, the deformable pre-formed curvature of each hook section 35-H, when un-deformed, is defined by a single radius of about 0.05 inch; and a length of each tip section 35-T is 0.064 inch±0.005 inch.



FIGS. 3C-D are plan views of alternate tine embodiments prior to being formed into the configuration of FIG. 3A, wherein tine 303-105° of FIG. 3C is suitable for an exemplary component 300 in which angle γ is about 105 degrees, and wherein tine 303—90° of FIG. 3D is suitable for an exemplary component 300 in which angle φ is about 90 degrees. With further reference to FIGS. 3C-D, an exemplary width w of each tine 303 is 0.028 inch±0.001 inch, and, in the tine embodiment of FIG. 3C, rounded free distal end 352 of tine 303—105° has an enlarged width defined by a diameter of 0.030 inch±0.001 inch.



FIG. 4 is a plan view of medical device system with a partial cut-away section, according to some embodiments, wherein the system includes device 20 and a delivery tool 400, in which device 20 is loaded for deployment to a target implant site. FIG. 4 illustrates tool 400 including a handle 410, an elongate outer member 430, and an elongate inner member 420 that extends within lumen 435 of outer member 430. FIG. 4 further illustrates inner member 420 including a distal end 422, which is configured to engage implantable medical device 20 by abutting proximal end 201 of device housing 205, as shown in the cut-away section. An entirety of device 20 is shown loaded within a tubular sidewall 432 that defines a distal portion of outer member lumen 435, for example, having been loaded therein by pulling device 20, with housing proximal end 201 leading, in through lumen distal opening 403. According to the illustrated embodiment, an inner surface 42 of tubular sidewall 432 engages tines 303 (or 703 as described below in conjunction with FIG. 6A), as device 20 is loaded into lumen 435, to deform tines 303, per arrow L of FIG. 3A, and then to hold each tine 303 of the loaded device 20 in a spring-loaded condition, which is described below in conjunction with FIG. 5A. According to the above-described exemplary embodiments of fixation component 300, with device housing 205 sized to an outer diameter of about 0.26 inch (20 French), a diameter of lumen 435, defined by inner surface 42, is about 0.28 inch (21 French).


With further reference to FIG. 4, a proximal end of outer member 430 is coupled to a control member 412 of handle 410 such that an entirety of outer member 430 is movable with respect to inner member 420, via control member 412, for example, so that an operator may retract outer member 430, per arrow W, relative to device 20 and inner member 420, to deploy device 20 out through distal opening 403, after positioning the system in proximity to a target implant site. The operator may position the system by advancing tool 400 through a venous system of the patient, for example, from a femoral venous access site and up through the inferior vena cava IVC (FIG. 1). Delivery tool 400 may include articulating features to facilitate the navigation of the distal portion of delivery tool 400. For example, inner member 420 of delivery tool 400 may include a pull wire assembly (not shown) integrated therein and being coupled to another control member 411 of handle 410 that, when moved per arrow A, causes inner member 420 and outer member 430 to bend along distal portions thereof. A length of outer member 430, between handle 410 and distal opening 403, when outer member 430 is in the position shown in FIG. 4, may be between about 103 cm and about 107 cm, for example, to reach into the right atrium RA from the femoral access site. Suitable construction detail for a delivery tool like tool 400 is described in co-pending and commonly assigned U.S. Patent Application 2015/0094668, Ser. No. 14/039,937 (filed on Sep. 27, 2013), the description of which is hereby incorporated by reference.


According to some methods, once the operator has advanced the system of FIG. 4 into atrial appendage 102 (FIG. 1), so that distal opening 403 abuts pectinate muscle PM therein (FIG. 2B) at the target implant site, the operator can move control member 412, per arrow B, to retract outer member 430 relative to device 20 and thereby release the spring loading of fixation component 300 so that tines 303 engage with pectinate muscle PM to secure device 20 at the implant site, as illustrated in FIG. 2B. However, it should be noted that, according to alternative embodiments and methods, delivery tool 400 may be configured so that an operator can advance inner member 420 relative to outer member 430 to push device 20 out through distal opening 403 for deployment. FIGS. 5A-F are schematics outlining a sequence of events corresponding to the release of above-described embodiments of fixation tines 303. (Although the schematics show tines 303 integrally formed with base 301, as in above-described embodiments of component 300, it should be understood that the sequence of events in FIGS. 5A-F may also apply to alternate embodiments in which tines 303 are not integrally formed with base 301.) FIG. 5A illustrates a maximum deformation of tines 303 when held in the spring-loaded condition by the engagement of rounded free distal end 352 with inner surface 42 of outer member tubular sidewall 432, wherein proximal, spring portion 33 becomes relatively straightened, and a location of the maximum principle strain along each tine 303 is in relatively close proximity to base 301 (designated by dashed-line circle). With reference back to FIG. 3A, the aforementioned exemplary length of distal portion tip section 35-T and the aforementioned associated angle γ (no less than 90 degrees) help to keep the deformed tines 303 from touching one another within lumen 435 and to prevent free distal ends 352 from being pulled proximally, per arrow P, when outer member 430 is retracted to release the spring loading of tines 303. FIG. 5A further illustrates tip section 35-T extending away from axis 3 at an acute angle δ, which is preferably in a range from about 45 degrees to about 75 degrees for an initial release of the spring loading of each tine 303, upon retraction of outer member 430, as depicted in FIG. 5B. With reference to FIG. 5C, once free distal end 352 is released from engagement with inner surface 42 for deployment into tissue at the implant site, the spring force of proximal, spring portion 33 and the pre-formed curvature of distal portion hook section 35-T cause distal portion tip section 35-T to immediately rotate away from axis 3 to an angle 7C, which approaches 90 degrees, so that tip section 35-T is oriented approximately normal to axis 3 for initial penetration of pectinate muscle PM. Thus each tine free distal end 352 is deployed in a direction toward pectinate muscle PM that ultimately prevents tines 303 from perforating the underlying visceral pericardium VP (reference FIG. 2B). FIGS. 5D-F illustrates the subsequent movement of tines 303, being driven by the release of proximal, spring portion 33 from the spring loading. According to the illustrated embodiment, this release of proximal, spring portion 33 causes free distal end 352, after penetrating through pectinate muscle PM in a first direction, at a first location P1, to penetrate back through in an opposite direction, at a second location P2, so that device 20 may be securely fixed at the implant site, as illustrated in FIG. 2B.


The configuration of tine distal portion 35, for example, embodied by the aforementioned exemplary lengths of proximal section 35-P and tip section 35-T, and the pre-formed curvature of hook section 35-H, provide a structural stiffness and reach to each tine 303 that is sufficient for deformation and subsequent penetration of free distal end 352 through pectinate muscle PM, as shown in FIG. 2B, but is not sufficient for penetration through visceral pericardium VP. Even if the operator ends up advancing the system into appendage 102 so that distal opening 403 of tool 400 abuts visceral pericardium VP, between folds of pectinate muscle PM, free distal end 352, according to this configuration of tines 303, is not backed-up by sufficient stiffness to penetrate through visceral pericardium VP, so tip section 35-T of tine distal portion 35 is redirected, laterally, toward pectinate muscle PM.


It should be noted that an operator may employ tines 303 to secure device 20 in atrial appendage 102 in an alternative fashion, wherein tines 303 are fully released from the spring-loaded condition without engaging any tissue (FIG. 5F), and then device 20 is advanced to the implant site so that tines 303 wedge between opposing surfaces of pectinate muscle PM within atrial appendage 102 to secure device 20 in place.


With reference back to FIGS. 2A-B, according to some preferred embodiments, for example, in order to assure intimate contact of electrode 206 with tissue, when fixation tines 303 secure device 20 at a target implant site, electrode 206 is spaced distally apart from device housing distal end 202 by a distance along longitudinal axis 2. Electrode 206 may be approximately flush with an intersection between proximal, spring portion 33 and distal portion 35, or spaced distally apart from the intersection by a distance X that may be up to about 2 mm, as depicted in FIG. 2A.



FIG. 6A-B are elevation and end views of an exemplary fixation component 700 which may be employed by device 20, according to some additional embodiments. FIGS. 6A-B illustrate component 700 including a base 701 from which a plurality of tines 703 extend, being spaced apart from one another around a perimeter of base 701. In FIG. 6A, a longitudinal axis 7 of component 700 is shown being defined by base 701 such that, when base 701 is mounted around distal end 202 of device housing 205, so that a perimeter of component 700 extends around electrode 206, axis 7 is generally aligned along longitudinal axis 2 of device 20 (FIG. 2A). With reference to FIG. 6B, base 701 may have an inner diameter id of about 0.20 inch and an outer diameter od of about 0.21 inch.


Like component 300, component 700 may be cut from the aforementioned medical grade Nitinol tubing, and each tine 703, integrally formed with base 701, may have a constant thickness t of 0.005 inch±0.001 inch. After cutting the tubing, tines 703 are shaped into the configuration shown in FIG. 6A by bending and holding tines 703, while heat treating according to methods known to those skilled in the art. FIG. 6A illustrates each tine 703 including a proximal, spring portion 73 and distal portion 75, which is terminated by a rounded free distal end 752, wherein both portions 73, 75 are pre-formed into, and elastically deformable from the illustrated shape. The shaped configuration and width of each tine 703, along with the super-elastic stiffness properties of Nitinol, provide a sufficient spring force and structural stiffness for tines 703 to engage tissue for the fixation of device 20 at an implant site when deployed by delivery tool 400, as described above for component 300. Furthermore, each tine 703, when device 20 is loaded in delivery tool 400, becomes deformed as generally shown in FIG. 4.


According to the illustrated embodiment, each proximal, spring portion 73 is fixedly attached to base 701 and has a spring-biased pre-formed curvature, which, in proximity to the base, extends in a first direction d1, generally parallel to axis 7, and then sweeps laterally, outward from axis 7 to a proximal section 73-P of distal portion 75. Proximal section 73-P is shown pre-formed to extend in a second direction d2 and along a relatively straight line (dashed line), being oriented, by the spring-biased pre-formed curvature of proximal, spring portion 73, so that second direction d2 is generally opposite first direction d1, and the relatively straight line intersects axis 7 at acute angle θ, which, according to some embodiments, is between about 30 degrees and about 50 degrees. In an exemplary embodiment of component 700, to be employed by an exemplary embodiment of device 20 that has housing 205 sized to an outer diameter of about 0.26 inch (20 French), the spring-biased pre-formed curvature of each proximal, spring portion 73 is defined by a single radius of 0.067 inch±0.010 inch; a distance A between base 701 and each intersection of proximal, spring portion 73 and distal portion proximal segment 75-P is 0.092 inch±0.005 inch; a length of each spring segment distal segment 73-D is 0.085 inch±0.005 inch; and angle θ is about 34 degrees.


With further reference to FIG. 6A, each distal portion 75 further includes a hook section 75-H, which has a deformable pre-formed curvature extending from distal proximal, spring portion 73 back toward axis 7, and a tip section 75-T, which is pre-formed to extend along a relatively straight line. Tip section 75-T is shown oriented, by un-deformed hook segment 74, to extend toward axis 7, such that tip section 75-T and proximal section 75-D enclose an angle φ, which may be about 70 degrees. According to the illustrated embodiment, distal portion hook section 75-H is defined by proximal and distal radii 75-HRp, 75-HRd, and a straight length 75-HS that extends therebetween. In the aforementioned exemplary embodiment of component 700, each hook section proximal radius 75-HRp, when un-deformed, is about 0.040 inch, each hook section distal radius 75-HRd is about 0.030 inch, and each straight length 75-HS is about 0.040 inch; and a length of each tip section 75-T is 0.062 inch±0.005 inch. It is contemplated that this double radius configuration of distal portion hook sections 75-H of component 700 enhances a stability of fixation for device 20 over that of component 300, by a decreased stiffness of tines 703 in proximity to free distal end 752 and additional spring energy to draw each tine 703 further away from the aforementioned second location P2 of penetration through pectinate muscle PM (FIG. 2B).



FIGS. 6C-D are plan views of alternate embodiments of each tine 703, prior to being formed into the configuration of FIG. 6A, wherein exemplary dimensions, in inches, for the alternate embodiments are shown. FIGS. 6C-D illustrate rounded free distal end 752 of each tine 703 having an enlarged width, for example, defined by a diameter of 0.032 inch±0.001 inch. FIG. 6C-D further illustrate a tapering width along a length of each tine 703, wherein proximal, spring portion 73 tapers from a first width w1 in proximity to base to a smaller second width w2. The tapering width may be employed to tailor spring energy and stiffness of tines, for example, to prevent tissue erosion and to enhance the fatigue life of tines 703 over the term of an implant.


In the foregoing detailed description, specific exemplary embodiments have been described. However, it may be appreciated that various modifications and changes can be made without departing from the scope of the invention as set forth in the appended claims.

Claims
  • 1. An implantable medical device (IMD) including a device body extending along a longitudinal axis from a proximal end to a distal end, an electrode mounted in proximity to the distal end of the device body, and a fixation mechanism comprising a plurality of tines formed from an elastically deformable material, each tine of the plurality of tines being fixedly mounted and spaced from one another around a perimeter of the distal end of the device body, wherein each tine of the plurality of tines comprises: a proximal portion being fixedly attached to the device body, wherein the proximal portion is configured to extend from the device body in a first direction, and wherein the proximal portion is configured to define a first pre-formed curvature; anda distal portion comprising: a proximal section configured to extend from the first pre-formed curvature of the proximal portion in a second direction along a relatively straight line;a hook section extending from the proximal section, wherein the hook section is configured to define a second pre-formed curvature; anda tip section extending from the hook section to a free distal end,wherein, when in a deployed configuration, an intersection between the proximal portion and the distal portion of each tine of the plurality of tines is spaced distally from the distal end of the device body, andwherein the electrode is flush with, or spaced distally from the intersection between the proximal portion and the distal portion by a distance less than or equal to about 2 mm.
  • 2. The device of claim 1, wherein each tine of the fixation mechanism has a constant thickness of about 0.005 inch and a width no less than about 0.02 inch, and wherein the width of each tine tapers from a greater width in proximity to the device body to a lesser width in proximity to the hook section of the distal portion.
  • 3. The device of claim 2, wherein the free distal end of each tine of the fixation mechanism has an enlarged width relative to a remainder of the tip section of the corresponding distal portion.
  • 4. The device of claim 1, wherein the first pre-formed curvature of the proximal portion of each tine of the fixation mechanism is defined by a radius, when undeformed, within a range from about 0.06 inch and about 0.08 inch.
  • 5. The device of claim 1, wherein the tip section of the distal portion of each tine of the fixation mechanism has a length of about 0.06 inch.
  • 6. The device of claim 1, wherein the proximal section of the distal portion of each tine of the fixation mechanism has a length of about 0.1 inch.
  • 7. The device of claim 1, wherein, when in a deployed configuration, the second pre-formed curvature of the hook section of the distal portion of each tine of the fixation mechanism is defined by a radius, when un-deformed, being about 0.05 inch.
  • 8. The device of claim 1, wherein, when in a deployed configuration, the second pre-formed curvature of the hook section of the distal portion of each tine of the fixation mechanism is defined by two radii and a straight length extending therebetween.
  • 9. The device of claim 1, wherein the elastically deformable material comprises a nickel-titanium alloy.
  • 10. The device of claim 1, wherein a length from the second pre-formed curvature to the distal free end is configured such that, when the tine is released from the spring-loaded position to the pre-formed position with the free distal end adjacent to the pectinate muscle of a heart, the tine penetrates the pectinate muscle without penetrating the tissue layer of heart beneath the pectinate muscle.
  • 11. The device of claim 1, wherein the relatively straight line of the proximal section of the distal portion of each tine of the plurality of tines and the longitudinal axis of the device body define an acute angle within a range from about 30 degrees and about 50 degrees.
  • 12. The device of claim 11, wherein the acute angle is about 45 degrees.
  • 13. The device of claim 1, wherein, when in the deployed configuration, the second pre-formed curvature of the hook section of the distal portion of each tine of the plurality of tines orients the corresponding tip section to enclose, with the corresponding proximal section, an angle of from about 70 degrees to about 120 degrees.
  • 14. The device of claim 13, wherein the angle is no less than about 90 degrees.
  • 15. The device of claim 1, wherein the relatively straight line of the proximal section of the distal portion of each tine of the plurality of tines intersects the longitudinal axis of the device body at an acute angle within a range from about 30 degrees and about 50 degrees, andwherein, when in a deployed configuration, the second pre-formed curvature of the hook section of the distal portion of each tine of the plurality of tines orients the corresponding tip section to enclose, with the corresponding proximal section, an angle of from about 70 degrees to about 120 degrees.
  • 16. The device of claim 1, wherein each tine of the plurality of tines is configured such that, when released from a spring-loaded position to a pre-formed position with the free distal end adjacent to a pectinate muscle of a heart, each tine penetrates the pectinate muscle without penetrating a tissue layer of heart beneath the pectinate muscle.
  • 17. An implantable medical device (IMD) including a device body extending along a longitudinal axis from a proximal end to a distal end, an electrode mounted in proximity to the distal end of the device body, and a fixation mechanism comprising a plurality of tines formed from an elastically deformable material, each tine of the plurality of tines being fixedly mounted and spaced from one another around a perimeter of the distal end of the device body, wherein each tine of the plurality of tines, when in a deployed configuration, comprises: a proximal portion fixedly attached to the device body and extending from the device body in a first direction, wherein the proximal portion comprises a first pre-formed curvature;a distal portion comprising a proximal section extending from the first pre-formed curvature, the distal portion comprising a hook section extending from the proximal section, and the hook section defining a second pre-formed curvature;a tip section extending from the hook section to a free distal end, wherein the hook section is configured to orient the free distal end to enclose with the proximal section an angle within a range from about 70 degrees to about 120 degrees.
  • 18. The device of claim 17, wherein the proximal section defines a relatively straight line which intersects the longitudinal axis at an acute angle within a range from about 30 degrees and about 50 degrees.
  • 19. The device of claim 17, wherein the angle is greater than or equal to about 90 degrees.
  • 20. The device of claim 17, wherein the elastically deformable material comprises a nickel-titanium alloy.
  • 21. An implantable medical device (IMD) defining a longitudinal axis extending between a proximal end and a distal end, the IMD comprising: an electrode mounted in proximity to the distal end;a fixation mechanism comprising a plurality of tines formed from an elastically deformable material, each tine of the plurality of tines being fixedly mounted and spaced from one another around a perimeter of the distal end of the IMD, and each tine of the plurality of tines, wherein, when in a deployed configuration, each tine of the plurality of tines comprises: a proximal portion fixedly attached to the IMD and extending therefrom, wherein the proximal portion comprises a first pre-formed curvature;a distal portion comprising a proximal section extending from the first pre-formed curvature and comprising a hook section extending from the proximal section, the hook section defining a second pre-formed curvature,wherein the proximal section extends along a relatively straight line that intersects the longitudinal axis distal to the distal end of the IMD, the relatively straight line intersecting the longitudinal axis at an acute first angle within a range from about 30 degrees and about 50 degrees; anda tip section extending from the hook section to a free distal end.
  • 22. The system of claim 21, wherein each tine of the plurality of tines is configured such that, upon deployment of the tip section thereof out from a distal opening of a delivery tool, each tip section rotates away from the longitudinal axis to extend at a second angle that approaches 90 degrees relative to the longitudinal axis.
  • 23. The system of claim 21, wherein the second angle is greater than or equal to about 90 degrees.
  • 24. The system of claim 21, wherein, when in the deployed configuration: the first pre-formed curvature of each tine of the plurality of tines is spaced distally from the distal end of the device body; andthe electrode is flush with, or spaced distally from the first pre-formed curvature by a distance less than or equal to about 2 mm.
  • 25. The device of claim 1, wherein the first pre-formed curvature is defined by a first radius and the second pre-formed curvature is defined by a second radius less than the first radius.
  • 26. The device of claim 1, wherein at least one of a position of the first pre-formed curvature, a position of the second pre-formed curvature, a radius of curvature of the first pre-formed curvature, or a radius of curvature of the second pre-formed curvature is configured such that, when the tine is released from the spring-loaded position to the pre-formed position with the free distal end adjacent to the pectinate muscle of a heart, the tine penetrates the pectinate muscle without penetrating the tissue layer of heart beneath the pectinate muscle.
  • 27. A medical device system including an implantable medical device (IMD), the IMD comprising: a device body extending along a longitudinal axis from a proximal end to a distal end;an electrode mounted in proximity to the distal end of the device body; anda fixation mechanism comprising a plurality of tines formed from an elastically deformable material, each tine of the plurality of tines being fixedly mounted and spaced from one another around a perimeter of the distal end of the device body, wherein each tine of the plurality of tines, when in a deployed configuration, comprises:a proximal portion fixedly attached to the device body and extending therefrom;a distal portion comprising a proximal section extending from the first pre-formed curvature, the distal portion comprising a hook section extending from the proximal section, and the hook section defining a second pre-formed curvature,wherein each tine of the plurality of tines is configured such that, upon deployment of the tip section thereof out from a distal opening of a delivery tool, each tip section rotates away from the longitudinal axis to extend at an angle that approaches 90 degrees relative to the longitudinal axis; andwherein, when in a deployed configuration, an intersection between the proximal portion and the distal portion of each tine of the plurality of tines is spaced distally from the distal end of the device body, andwherein the electrode is flush with, or spaced distally from the intersection between the proximal portion and the distal portion by a distance less than or equal to about 2 mm; anda tip section extending from the hook section to a free distal end.
  • 28. The medical device system of claim 27, further comprising the delivery tool, wherein the delivery tool comprises a tubular sidewall that defines a lumen having the distal opening, wherein the IMD may be loaded into the lumen and deployed through the distal opening, and wherein, when loaded into the lumen of the delivery tool in an undeployed configuration, the free distal end of each tine of the plurality of tines is configured to engage the tubular sidewall to hold each tine of the plurality of tines in a spring-loaded condition.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of U.S. patent application Ser. No. 16/158,724, filed Oct. 12, 2018, entitled “Interventional Medical Devices, Device Systems, and Fixation Components Thereof”, which is a Continuation of U.S. patent application Ser. No. 15/410,161, filed Jan. 19, 2017, entitled “Interventional Medical Devices, Device Systems, and Fixation Components Thereof”, which claims the benefit of the filing date of Provisional U.S. Patent Application No. 62/281,403, filed Jan. 21, 2016, entitled “Interventional Medical Devices, Device Systems, and Fixation Components Thereof”, the content of each of which is incorporated by reference in their entirety.

US Referenced Citations (365)
Number Name Date Kind
3717151 Collett Feb 1973 A
3754555 Schmitt Aug 1973 A
3814104 Irnich et al. Jun 1974 A
3835864 Rasor et al. Sep 1974 A
3902501 Citron et al. Sep 1975 A
3943936 Rasor Mar 1976 A
3971364 Fletcher et al. Jul 1976 A
3976082 Schmitt Aug 1976 A
4103690 Harris Aug 1978 A
4112952 Thomas et al. Sep 1978 A
4142530 Wittkampf Mar 1979 A
4236529 Little Dec 1980 A
4269198 Stokes May 1981 A
4280512 Karr Jul 1981 A
4301815 Doring Nov 1981 A
4402328 Doring Sep 1983 A
4409994 Doring Oct 1983 A
4502492 Bornzin Mar 1985 A
4662382 Sluetz et al. May 1987 A
4858623 Bradshaw et al. Aug 1989 A
4898577 Badger et al. Feb 1990 A
4913164 Greene et al. Apr 1990 A
4936823 Colvin Jun 1990 A
5003990 Osypka Apr 1991 A
5057114 Wittich et al. Oct 1991 A
5129749 Sato Jul 1992 A
5171233 Amplatz et al. Dec 1992 A
5193540 Schulman et al. Mar 1993 A
5257634 Kroll Nov 1993 A
5267960 Hayman et al. Dec 1993 A
5282845 Bush et al. Feb 1994 A
5300107 Stokes et al. Apr 1994 A
5318528 Heaven et al. Jun 1994 A
5336253 Gordon et al. Aug 1994 A
5405367 Schulman et al. Apr 1995 A
5405374 Stein Apr 1995 A
5411535 Fujii et al. May 1995 A
5425756 Heil et al. Jun 1995 A
5443492 Stokes et al. Aug 1995 A
5492119 Abrams Feb 1996 A
5522875 Gates et al. Jun 1996 A
5522876 Rusink Jun 1996 A
5545201 Helland et al. Aug 1996 A
5545206 Carson Aug 1996 A
5562723 Rugland et al. Oct 1996 A
5573540 Yoon Nov 1996 A
5575814 Giele et al. Nov 1996 A
5578068 Laske et al. Nov 1996 A
5683447 Bush et al. Nov 1997 A
5697936 Shipko et al. Dec 1997 A
5716390 Li Feb 1998 A
5716391 Grandjean Feb 1998 A
5755764 Schroeppel May 1998 A
5776178 Pohndorf et al. Jul 1998 A
5807399 Laske et al. Sep 1998 A
5837006 Ocel et al. Nov 1998 A
5837007 Altman et al. Nov 1998 A
5851226 Skubitz et al. Dec 1998 A
5871531 Struble Feb 1999 A
5908381 Aznoian et al. Jun 1999 A
5908447 Schroeppel et al. Jun 1999 A
5971993 Hussein et al. Oct 1999 A
6007558 Ravenscroft et al. Dec 1999 A
6041258 Cigaina et al. Mar 2000 A
6055457 Bonner Apr 2000 A
6074401 Gardnier et al. Jun 2000 A
6078840 Stokes Jun 2000 A
6093177 Javier et al. Jul 2000 A
6129749 Bartig et al. Oct 2000 A
6132456 Sommer et al. Oct 2000 A
6151525 Soykan et al. Nov 2000 A
6181973 Ceron et al. Jan 2001 B1
6188932 Lindegren Feb 2001 B1
6240322 Peterfeso et al. May 2001 B1
6251104 Kesten et al. Jun 2001 B1
6286512 Loeb et al. Sep 2001 B1
6290719 Garberoglio Sep 2001 B1
6321124 Cigaina Nov 2001 B1
6322548 Payne et al. Nov 2001 B1
RE37463 Altman Dec 2001 E
6358256 Reinhardt Mar 2002 B1
6363938 Saadat et al. Apr 2002 B2
6381495 Jenkins Apr 2002 B1
6381500 Fischer, Sr. Apr 2002 B1
6408214 Williams et al. Jun 2002 B1
6409674 Brockway et al. Jun 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6477423 Jenkins Nov 2002 B1
6500182 Foster Dec 2002 B2
6510332 Greenstein Jan 2003 B1
6510345 Van Bentem Jan 2003 B1
6522915 Ceballos et al. Feb 2003 B1
6572587 Lerman et al. Jun 2003 B2
6575967 Leveen et al. Jun 2003 B1
6582441 He et al. Jun 2003 B1
6592581 Bowe Jul 2003 B2
6623518 Thompson et al. Sep 2003 B2
6626915 Leveillee Sep 2003 B2
6638268 Niazi Oct 2003 B2
6684109 Osypka Jan 2004 B1
6711443 Osypka Mar 2004 B2
6738672 Schulman et al. May 2004 B2
6743240 Smith et al. Jun 2004 B2
6755812 Peterson et al. Jun 2004 B2
6783499 Schwartz Aug 2004 B2
6823217 Rutten et al. Nov 2004 B2
6909920 Lokhoff et al. Jun 2005 B2
6915149 Ben-Haim Jul 2005 B2
6944507 Froberg Sep 2005 B2
6953454 Peterson et al. Oct 2005 B2
6978178 Sommer et al. Dec 2005 B2
7027876 Casavant et al. Apr 2006 B2
7082335 Klein et al. Jul 2006 B2
7082336 Ransbury et al. Jul 2006 B2
7085606 Flach et al. Aug 2006 B2
7092765 Geske et al. Aug 2006 B2
7092766 Salys et al. Aug 2006 B1
7120504 Osypka Oct 2006 B2
7130700 Gardeski et al. Oct 2006 B2
7149587 Wardle et al. Dec 2006 B2
7158838 Seifert et al. Jan 2007 B2
7162310 Doan Jan 2007 B2
7181288 Rezai et al. Feb 2007 B1
7187982 Seifert et al. Mar 2007 B2
7200437 Nabutovsky et al. Apr 2007 B1
7212869 Wahlstrom et al. May 2007 B2
7229415 Schwartz Jun 2007 B2
7251532 Hess et al. Jul 2007 B2
7289853 Campbell et al. Oct 2007 B1
7290743 Nowack Nov 2007 B2
7313445 McVenes et al. Dec 2007 B2
7326231 Phillips et al. Feb 2008 B2
7328071 Stehr et al. Feb 2008 B1
7331922 Mohl Feb 2008 B2
7383091 Chitre et al. Jun 2008 B1
7418298 Shiroff et al. Aug 2008 B2
7450999 Karicherla et al. Nov 2008 B1
7462184 Worley et al. Dec 2008 B2
7463933 Wahlstrom et al. Dec 2008 B2
7499758 Cates et al. Mar 2009 B2
7509169 Eigler et al. Mar 2009 B2
7515971 Doan Apr 2009 B1
7532939 Sommer et al. May 2009 B2
7558631 Cowan et al. Jul 2009 B2
7634319 Schneider et al. Dec 2009 B2
7647109 Hastings et al. Jan 2010 B2
7657325 Williams Feb 2010 B2
7678128 Boyle et al. Mar 2010 B2
7717899 Bowe et al. May 2010 B2
7731655 Smith et al. Jun 2010 B2
7734343 Ransbury et al. Jun 2010 B2
7740640 Ginn Jun 2010 B2
7785264 Hettrick et al. Aug 2010 B2
7799037 He et al. Sep 2010 B1
7801624 Flannery et al. Sep 2010 B1
7835801 Sundararajan et al. Nov 2010 B1
7840281 Kveen et al. Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7860580 Falk et al. Dec 2010 B2
7875049 Eversull et al. Jan 2011 B2
7890186 Wardle et al. Feb 2011 B2
7904179 Rutten et al. Mar 2011 B2
7920928 Yang et al. Apr 2011 B1
7949395 Kuzma May 2011 B2
7993351 Worley et al. Aug 2011 B2
8010209 Jacobson Aug 2011 B2
8012127 Lieberman et al. Sep 2011 B2
8032219 Neumann et al. Oct 2011 B2
8036757 Worley Oct 2011 B2
8057486 Hansen Nov 2011 B2
8082035 Glukhovsky Dec 2011 B2
8103361 Moser Jan 2012 B2
8108054 Helland Jan 2012 B2
8142347 Griego et al. Mar 2012 B2
8160722 Rutten et al. Apr 2012 B2
8170690 Morgan et al. May 2012 B2
8185213 Kveen et al. May 2012 B2
8219213 Sommer et al. Jul 2012 B2
8233994 Sommer et al. Jul 2012 B2
8252019 Fleming, III Aug 2012 B2
8262672 Neidert et al. Sep 2012 B2
8295939 Jacobson Oct 2012 B2
8313445 Mishima et al. Nov 2012 B2
8352025 Jacobson Jan 2013 B2
8352028 Wenger Jan 2013 B2
8353940 Benderev Jan 2013 B2
8364277 Glukhovsky Jan 2013 B2
8364280 Marnfeldt et al. Jan 2013 B2
8406900 Barlov et al. Mar 2013 B2
8406901 Starkebaum et al. Mar 2013 B2
8418362 Zerfas et al. Apr 2013 B2
8428750 Kolberg Apr 2013 B2
8452420 Flach et al. May 2013 B2
8478431 Griswold et al. Jul 2013 B2
8489189 Tronnes Jul 2013 B2
8494650 Glukhovsky et al. Jul 2013 B2
8504156 Bonner et al. Aug 2013 B2
8518060 Jelich et al. Aug 2013 B2
8527068 Ostroff Sep 2013 B2
8532790 Griswold Sep 2013 B2
8548605 Ollivier Oct 2013 B2
8565897 Regnier et al. Oct 2013 B2
8615310 Khairkhahan et al. Dec 2013 B2
8634912 Bornzin et al. Jan 2014 B2
8670842 Bornzin et al. Mar 2014 B1
8700181 Bornzin et al. Apr 2014 B2
8721587 Berthiaume et al. May 2014 B2
8727996 Allan et al. May 2014 B2
8738147 Hastings et al. May 2014 B2
8755909 Sommer et al. Jun 2014 B2
8758365 Bonner et al. Jun 2014 B2
9119959 Rys et al. Sep 2015 B2
9155882 Grubac et al. Oct 2015 B2
9283381 Grubac et al. Mar 2016 B2
9414857 Wood et al. Aug 2016 B2
9446248 Sheldon et al. Sep 2016 B2
9526522 Wood et al. Dec 2016 B2
9526891 Eggen et al. Dec 2016 B2
9539423 Bonner et al. Jan 2017 B2
10071243 Kuhn et al. Sep 2018 B2
10099050 Chen et al. Oct 2018 B2
10112045 Anderson et al. Oct 2018 B2
10463853 Drake et al. Nov 2019 B2
10518084 Kuhn et al. Dec 2019 B2
20020077556 Schwartz Jun 2002 A1
20020095203 Thompson et al. Jul 2002 A1
20020103424 Swoyer et al. Aug 2002 A1
20020165589 Imran et al. Nov 2002 A1
20030004537 Boyle et al. Jan 2003 A1
20030088301 King May 2003 A1
20030233139 Chitre et al. Dec 2003 A1
20040034401 Dahlberg et al. Feb 2004 A1
20040147973 Hauser Jul 2004 A1
20040176797 Opolski Sep 2004 A1
20040230280 Cates Nov 2004 A1
20040230281 Heil et al. Nov 2004 A1
20040249417 Ransbury et al. Dec 2004 A1
20040260346 Overall et al. Dec 2004 A1
20050038491 Biggs et al. Feb 2005 A1
20050090890 Wu et al. Apr 2005 A1
20050177182 Van Der Burg et al. Aug 2005 A1
20050267555 Marnfeldt et al. Dec 2005 A1
20060084965 Young Apr 2006 A1
20060085039 Hastings et al. Apr 2006 A1
20060085041 Hastings et al. Apr 2006 A1
20060247753 Wenger et al. Nov 2006 A1
20060293628 Hunt et al. Dec 2006 A1
20070043414 Fifer et al. Feb 2007 A1
20070043441 Pisharodi Feb 2007 A1
20070088394 Jacobson Apr 2007 A1
20070135882 Drasler et al. Jun 2007 A1
20070135883 Drasler et al. Jun 2007 A1
20070150037 Hastings et al. Jun 2007 A1
20070150038 Hastings et al. Jun 2007 A1
20070233218 Kolberg Oct 2007 A1
20070239248 Hastings et al. Oct 2007 A1
20070255376 Michels et al. Nov 2007 A1
20070276444 Gelbart Nov 2007 A1
20070293904 Gelbart Dec 2007 A1
20080021532 Kveen et al. Jan 2008 A1
20080051863 Schneider Feb 2008 A1
20080109054 Hastings May 2008 A1
20090082827 Kveen et al. Mar 2009 A1
20090082828 Ostroff Mar 2009 A1
20090204170 Hastings et al. Aug 2009 A1
20090281605 Marnfeldt et al. Nov 2009 A1
20100131036 Geistert et al. May 2010 A1
20100198288 Ostroff Aug 2010 A1
20100211149 Morgan et al. Aug 2010 A1
20110034939 Kveen et al. Feb 2011 A1
20110054555 Williams et al. Mar 2011 A1
20110112548 Fifer et al. May 2011 A1
20110125163 Rutten et al. May 2011 A1
20110190785 Gerber et al. Aug 2011 A1
20110190786 Gerber et al. Aug 2011 A1
20110208260 Jacobson Aug 2011 A1
20110237967 Moore et al. Sep 2011 A1
20110251660 Griswold Oct 2011 A1
20110251661 Fifer et al. Oct 2011 A1
20110251662 Griswold et al. Oct 2011 A1
20110270339 Murray, III et al. Nov 2011 A1
20110270340 Pellegrini et al. Nov 2011 A1
20110282423 Jacobson Nov 2011 A1
20110307043 Ollivier Dec 2011 A1
20120078322 Dal Molin et al. Mar 2012 A1
20120078336 Helland Mar 2012 A1
20120095539 Khairkhahan et al. Apr 2012 A1
20120108986 Beasley et al. May 2012 A1
20120109002 Mothilal et al. May 2012 A1
20120109079 Asleson et al. May 2012 A1
20120109148 Bonner et al. May 2012 A1
20120109149 Bonner et al. May 2012 A1
20120116489 Khairkhahan et al. May 2012 A1
20120158111 Khairkhahan et al. Jun 2012 A1
20120165827 Khairkhahan et al. Jun 2012 A1
20120172690 Anderson Jul 2012 A1
20120172891 Lee Jul 2012 A1
20120172892 Grubac et al. Jul 2012 A1
20120197373 Khairkhahan et al. Aug 2012 A1
20120232565 Kveen et al. Sep 2012 A1
20120271134 Allan et al. Oct 2012 A1
20120330392 Regnier et al. Dec 2012 A1
20130006261 Lampropoulos et al. Jan 2013 A1
20130006262 Lampropoulos et al. Jan 2013 A1
20130012925 Berthiaume et al. Jan 2013 A1
20130035636 Beasley et al. Feb 2013 A1
20130035748 Bonner et al. Feb 2013 A1
20130053921 Bonner et al. Feb 2013 A1
20130079758 Goode et al. Mar 2013 A1
20130079798 Tran et al. Mar 2013 A1
20130079861 Reinert et al. Mar 2013 A1
20130103047 Steingisser et al. Apr 2013 A1
20130103049 Bonde Apr 2013 A1
20130110127 Bornzin et al. May 2013 A1
20130110219 Bornzin et al. May 2013 A1
20130116738 Samade et al. May 2013 A1
20130116740 Bornzin et al. May 2013 A1
20130116741 Bornzin et al. May 2013 A1
20130123875 Varady et al. May 2013 A1
20130131591 Berthiaume et al. May 2013 A1
20130131693 Berthiaume et al. May 2013 A1
20130233345 Baarsch et al. Sep 2013 A1
20130253342 Griswold et al. Sep 2013 A1
20130253343 Waldhauser et al. Sep 2013 A1
20130253344 Griswold et al. Sep 2013 A1
20130253345 Griswold et al. Sep 2013 A1
20130253346 Griswold et al. Sep 2013 A1
20130253347 Griswold et al. Sep 2013 A1
20130296957 Tronnes Nov 2013 A1
20130331940 Swanick et al. Dec 2013 A1
20140039591 Drasler et al. Feb 2014 A1
20140058494 Ostroff et al. Feb 2014 A1
20140074114 Khairkhahan et al. Mar 2014 A1
20140107723 Hou et al. Apr 2014 A1
20140148815 Wenzel et al. May 2014 A1
20140180306 Grubac et al. Jun 2014 A1
20140257324 Fain Sep 2014 A1
20150039069 Rys et al. Feb 2015 A1
20150039070 Kuhn et al. Feb 2015 A1
20150039071 Grubac et al. Feb 2015 A1
20150051616 Haasl Feb 2015 A1
20150051682 Schmidt et al. Feb 2015 A1
20150094668 Wood et al. Apr 2015 A1
20150352353 Rys et al. Dec 2015 A1
20160001068 Grubac et al. Jan 2016 A1
20160059002 Grubac et al. Mar 2016 A1
20160094668 Chang et al. Mar 2016 A1
20170209688 Drake et al. Jul 2017 A1
20170209689 Chen et al. Jul 2017 A1
20180071543 Taff et al. Mar 2018 A1
20190046789 Chen et al. Feb 2019 A1
20190083779 Yang et al. Mar 2019 A1
20190083800 Yang et al. Mar 2019 A1
20190269929 Bjorklund et al. Sep 2019 A1
20200078585 Eggen et al. Mar 2020 A1
20200121923 Kuhn et al. Apr 2020 A1
20200306522 Chen et al. Oct 2020 A1
20200398045 Anderson et al. Dec 2020 A1
20210016063 Drake et al. Jan 2021 A1
20210046306 Grubac et al. Feb 2021 A1
20210069491 Grubac et al. Mar 2021 A1
20210236814 Anderson et al. Aug 2021 A1
20210275824 Rock et al. Sep 2021 A1
20220032047 Fraysse et al. Feb 2022 A1
20220339435 Kuhn et al. Oct 2022 A1
Foreign Referenced Citations (29)
Number Date Country
1003904 Jan 1977 CA
2477207 Feb 2006 CA
1882370 Dec 2006 CN
105339039 Feb 2016 CN
2053919 May 1972 DE
0212955 Mar 1987 EP
779080 May 2003 EP
H0288666 Jul 1990 JP
05245215 Sep 1993 JP
2011151104 Jun 2013 RU
WO 9520993 Aug 1995 WO
WO 0102053 Jan 2001 WO
2002022202 Mar 2002 WO
WO 03032807 Apr 2003 WO
WO 2004028348 Apr 2004 WO
2006118865 Nov 2006 WO
WO 2009039400 Mar 2009 WO
WO 2009042295 Apr 2009 WO
WO 2010131157 Nov 2010 WO
WO 2012092067 Jul 2012 WO
WO 2012092074 Jul 2012 WO
WO 2012135530 Oct 2012 WO
WO 2014006471 Jan 2014 WO
2014087402 Jun 2014 WO
2015017273 Feb 2015 WO
WO 2015017234 Feb 2015 WO
2017127689 Jul 2017 WO
2017127695 Jul 2017 WO
2018081363 May 2018 WO
Non-Patent Literature Citations (47)
Entry
Office Action from U.S. Appl. No. 16/825,143, dated Aug. 3, 2021, 37 pp.
Response to Office Action mailed Aug. 3, 2021, from U.S. Appl. No. 16/825,143, filed Nov. 3, 2021, 19 pp.
Office Action from U.S. Appl. No. 16/718,528, dated Aug. 12, 2021, 8 pp.
First Office Action and Search Report, and translation thereof, from counterpart Chinese Application No. 201780018926.5, dated Jun. 25, 2021, 13 pp.
“Homer Mammalok Gold,” accessed on or about Jan. 19, 2017, accessed from http://www.mana-tech.com/factsheets/HomerMammalok.pdf, 1 pp.
Medtronic model SELECTSURE™ 3830 manual, 2013, accessed on or about Jan. 19, 2017, 20 pp.
Merriam-Webster Definition of “Compound Curve,” accessed on Apr. 25, 2017, https://merriam-webster.com/dictionary/compound%20curve, 4 pp.
Spickler, et al., “Totally Self-Contained Intracardiac Pacemaker,” J. Electrocardiology, vol. 3, Nos. 3 & 4, pp. 325-331, 1970. (Applicant points out, in accordance with MPEP 609.04(a), that the year of publication, 1970 is sufficiently earlier than the effective U.S. filing date, so that the particular month of publication is not in issue.).
(PCT/US2017/01435) PCT Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, mailed Apr. 3, 2017, 3 pages.
(PCT/US2017/014361) PCT Notification of Transmittal of the International Search report and the Written Opinion of the International Searching Authority, mailed Apr. 3, 2017, 11 pages.
(PCT/US2017/014352) PCT Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, mailed Apr. 3, 2017, 7 pages.
(PCT/US2017/014352) PCT Notification of Transmittal of the International Search report and the Written Opinion of the International Searching Authority, or the Declaration, mailed May 22, 2017, 8 pages.
(PCT/US2017/014369) PCT Notification of Transmittal of the International Search report and the Written Opinion of the International Searching Authority, mailed May 10, 2017, 13 pages.
International Search Report and Written Opinion of International Application No. PCT/US2020/024582, mailed Jul. 7, 2020, 8 pp.
Notice of Allowance from U.S. Appl. No. 15/410,161, dated Jun. 13, 2018, 5 pp.
Prosecution History from U.S. Appl. No. 16/158,724, dated Jul. 8, 2020 through Feb. 18, 2021, 50 pp.
U.S. Appl. No. 16/825,143, filed by Chen et al., filed on Mar. 20, 2020.
U.S. Appl. No. 62/825,233, filed by Xin Chen et al., filed on Mar. 28, 2019.
Prosecution History from U.S. Appl. No. 13/955,393, dated Sep. 17, 2014 through Aug. 16, 2018, 176 pp.
Prosecution History from U.S. Appl. No. 16/128,270, dated Nov. 26, 2018 through Aug. 21, 2019, 56 pp.
U.S. Appl. No. 16/718,528, filed Dec. 18, 2019, naming inventors Kuhn et al.
Prosecution History from U.S. Appl. No. 15/410,085, dated Nov. 2, 2018 through Oct. 2, 2019, 39 pp.
Advisory Action from U.S. Appl. No. 16/825,143, dated May 12, 2022, 3 pp.
Extended Search Report from counterpart European Application No. 22156586.4 dated Aug. 11, 2022, 8 pp.
Pre-Appeal Brief Request for Review and Notice of Appeal from U.S. Appl. No. 16/825,143, filed Jun. 10, 2022, 5 pp.
Response to Office Action dated Oct. 14, 2022 from U.S. Appl. No. 16/825,143, filed Jan. 17, 2023, 12 pp.
Final Office Action from U.S. Appl. No. 16/825,143 dated Feb. 15, 2023, 34 pp.
Final Office Action from U.S. Appl. No. 16/825,143, dated Feb. 10, 2022, 36 pp.
Haqqani et al., “The Implantable Cardioverter-Defibrillator Lead: Principles, Progress and Promises,” PACE, vol. 32, Oct. 2009, pp. 1336-1353.
Notice of Allowance from U.S. Appl. No. 16/718,528, dated Mar. 15, 2022, 8 pp.
Response to Final Office Action dated Feb. 10, 2022, from U.S. Appl. No. 16/825,143, filed Apr. 8, 2022, 16 pp.
Tjong et al., “Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator,” JACC: Clinical Electrophysiology, vol. 3, No. 13, Dec. 26, 2017, pp. 1487-1498.
Tjong et al., “The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD,” Herzschrittmachertherapie + Elektrophysiologie, vol. 29, Oct. 31, 2018, pp. 355-361.
Notice of Allowance from U.S. Appl. No. 16/718,528, dated Nov. 26, 2021, 7 pp.
Response to Office Action mailed Aug. 12, 2021, from U.S. Appl. No. 16/718,528, filed Nov. 12, 2021, 15 pp.
Office Action from U.S. Appl. No. 16/825,143 dated Oct. 14, 2022, 38 pp.
Notice of Allowance from U.S. Appl. No. 16/825,143 dated May 4, 2023, 10 pp.
Response to Final Office Action dated Feb. 15, 2023 from U.S. Appl. No. 16/825,143, filed Mar. 30, 2023, 14 pp.
Office Action from U.S. Appl. No. 17/812,099 dated Jun. 5, 2023, 10 pp.
Auricchio et al., “First-in-man implantation of leadless ultrasoundbased cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients”, EP Europace, vol. 15, No. 8, May 23, 2013, pp. 1191-1197.
Echt et al., “Feasibility and safety of a novel technology for pacing without leads”, Heart Rhythm, vol. 3, No. 10, Oct. 1, 2006, pp. 1202-1206.
Manolis, “Leadless Pacing: The Future is not Here Yet!”, Rhythmos, vol. 8, No. 1, Jan. 1, 2013, 3 pp.
Robicsek et al., “Self-anchoring endocardial pacemaker leads: Current spectrum of types, advances in design, and clinical results”, American Heart Journal, vol. 102, No. 4, Elsevier, Oct. 1, 1981, pp. 775-782.
Office Action from U.S. Appl. No. 18/469,331 dated Apr. 24, 2024, 29 pp.
Notice of Allowance from U.S. Appl. No. 18/529,373 dated Sep. 29, 2024, 7 pp.
Response to Office Action dated Jun. 14, 2024 from U.S. Appl. No. 18/529,373, filed Sep. 19, 2024, 10 pp.
Office Action from U.S. Appl. No. 18/529,373 dated Jun. 14, 2024, 11 pp.
Related Publications (1)
Number Date Country
20210252283 A1 Aug 2021 US
Provisional Applications (1)
Number Date Country
62281403 Jan 2016 US
Continuations (2)
Number Date Country
Parent 16158724 Oct 2018 US
Child 17306032 US
Parent 15410161 Jan 2017 US
Child 16158724 US